Drug Shortage Report for MAR-MONTELUKAST

Last updated on 2023-07-13 History
Report ID 136415
Drug Identification Number 02399873
Brand name MAR-MONTELUKAST
Common or Proper name MONTELUKAST
Company Name MARCAN PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30 Tablets
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-30
Actual start date 2021-03-30
Estimated end date 2022-09-26
Actual end date 2022-07-06
Shortage status Resolved
Updated date 2023-07-13
Company comments Business reasons
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-07-13 French Compare
v6 2023-07-13 English Compare
v5 2021-09-27 French Compare
v4 2021-09-27 English Compare
v3 2021-03-31 English Compare
v2 2021-03-26 French Compare
v1 2021-03-26 English Compare

Showing 1 to 7 of 7